Skripsi

ANALISIS HUBUNGAN KEPATUHAN PENGGUNAAN OBAT TERHADAP KUALITAS HIDUP PASIEN GAGAL GINJAL KRONIK DENGAN HEMODIALISA DI RSI SITI KHADIJAH PALEMBANG TAHUN 2023

---

Hemodialysis is the primary treatment for patients with Chronic Kidney Failure (CKD). CKD Patients experience disruptions in fluid balance, electrolyte levels, acid-base balance, hormone production, and the secretion of toxic metabolic waste. This study aims to analyze the relationship between adherence to medication use and the quality of life of CKD patients with hemodialysis therapy at RSI Siti Khadijah Palembang. This research is quantitative, observational and descriptive with a cross-sectional approach, which involved 30 respondents from CKD patients with hemodialysis therapy using questionnaire instruments and medical record. Data from the medication adherence questionnaire (MMAS-8) and patient quality of life (WHOQOL-BREF) were tested using the Kendall's Tau-b test which produced respondents with high adherence of 50%, moderate adherence of 43%, and low adherence of 7%, respondents with moderate quality of life 46.5%, high quality of life 37.2%, and low quality of life 16.3%. The statistical test results of p=0.000 with a correlation coefficient=0.652 show that there is a relationship between adherence to taking CKD medication undergoing Hemodialysis therapy and the quality of life of patients at RSI Siti Khadijah Palembang in 2023. The more compliant CKD patients with hemodialysis therapy are in taking medication, the better quality of life

---

Availability

Detail Information

Series Title

-

Call Number

T1581922024

Publisher

Indralaya : Prodi Farmasi, Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Sriwijaya., 2024

Collation

xiii, 69 hlm.; ilus.; 29 cm

Language

Indonesia

ISBN/ISSN

-

Classification

616.610 7

Content Type

Text

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

gagal ginjal kronik
Prodi Farmasi

Specific Detail Info

-

Statement of Responsibility

TUTI

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment